Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease Finance Desk 2 hours ago Read More Source link AbbVie’s Skyrizi gains pediatric psoriatic disease indicationDate26 June 2026In relation toMONEYEli Lilly: Next-gen weight loss drug may be more effective than othersDate21 May 2026In relation toTOP NEWSVertex gains expanded indication for Casgevy in children as young as twoDate1 July 2026In relation toMONEY
